Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

Figure 1

Hazard ratios in metformin-treated type 2 diabetes for cancer incidence for men (n = 8,167). Adjusted for age group, gender, other oral anti-hyperglycemic medication, CCI score, and duration of metformin exposure (a time dependent variable). Reference: Diabetes patients use oral anti-hyperglycemic medication except metformin.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us